Capital Impact Advisors, LLC Omnicell, Inc Transaction History

Capital Impact Advisors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$29.24 - $45.81 $191,141 - $299,459	6,537 Added 70.06%	15,867 $597,000
Q2 2023 Aug 14, 2023	SELL	$57.88 - $75.94 $241,185 - $316,441	-4,167 Reduced 30.87%	9,330 $687,000
Q1 2023 May 23, 2023	SELL	$51.51 - $60.43 $220,462 - $258,640	-4,280 Reduced 24.08%	13,497 $791,000
Q4 2022 Feb 14, 2023	BUY	$46.24 - $90.03 $253,996 - $494,534	5,493 Added 44.72%	17,777 $896,000
Q3 2022 Nov 21, 2022	SELL	$84.23 - $117.38 $8,591 - $11,972	-102 Reduced 0.82%	12,284 $779,000
Q2 2022 Aug 15, 2022	SELL	$105.64 - $129.11 $234,520 - $286,624	-2,220 Reduced 15.2%	12,386 $1.41 Million
Q1 2022 May 16, 2022	BUY	$120.68 - $180.51 $1.76 Million - $2.64 Million	14,606 New	14,606 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$153.26 - $183.62 $3.02 Million - $3.62 Million	-19,737 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$117.78 - $143.9 $1.67 Million - $2.04 Million	-14,201 Reduced 41.84%	19,737 $2.56 Million
Q2 2020 Aug 17, 2020	SELL	$59.36 - $74.43 $3,680 - $4,614	-62 Reduced 0.18%	33,938 $2.4 Million
Q1 2020 May 15, 2020	BUY	$55.41 - $90.19 $58,069 - $94,519	1,048 Added 3.18%	34,000 $2.23 Million
Q4 2019 Feb 13, 2020	BUY	$70.15 - $83.11 $697,992 - $826,944	9,950 Added 43.26%	32,952 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$68.36 - $88.34 $1.57 Million - $2.03 Million	23,002 New	23,002 $1.64 Million
Q1 2018 Apr 11, 2018	SELL	$40.1 - $52.45 $1.1 Million - $1.44 Million	-27,421 Closed	0 $0
Q3 2017 Jan 16, 2018	BUY	$48.1 - $52.15 $1.32 Million - $1.43 Million	27,421	27,421 $1.4 Million

274

44.3M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.